Advertisement

Topics

Novartis ties with Royal Marsden to boost cancer care

04:46 EST 9 Nov 2017 | PharmaTimes

Cancer patients living in North West and South West London are to benefit from a new Joint Working Project between Novartis and the Royal Marsden Partners Cancer Vanguard that aims to improve quality of care in the region by expanding the role of oncology pharmacists.

Original Article: Novartis ties with Royal Marsden to boost cancer care

NEXT ARTICLE

More From BioPortfolio on "Novartis ties with Royal Marsden to boost cancer care"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...